FI46839C - Förfarande för framställning av nya farmakologiskt värdefulla 2-amino- halogenbensylaminer. - Google Patents

Förfarande för framställning av nya farmakologiskt värdefulla 2-amino- halogenbensylaminer.

Info

Publication number
FI46839C
FI46839C FI142967A FI142967A FI46839C FI 46839 C FI46839 C FI 46839C FI 142967 A FI142967 A FI 142967A FI 142967 A FI142967 A FI 142967A FI 46839 C FI46839 C FI 46839C
Authority
FI
Finland
Prior art keywords
aminohalobenzylamines
preparation
pharmacologically valuable
new pharmacologically
new
Prior art date
Application number
FI142967A
Other languages
English (en)
Finnish (fi)
Other versions
FI46839B (sv
Original Assignee
Krueger
Nickl
Keck
Machleidt
Thomae Gmbh Dr K
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Krueger, Nickl, Keck, Machleidt, Thomae Gmbh Dr K filed Critical Krueger
Publication of FI46839B publication Critical patent/FI46839B/fi
Application granted granted Critical
Publication of FI46839C publication Critical patent/FI46839C/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36—Radicals substituted by singly-bound nitrogen atoms
    • C07D213/38—Radicals substituted by singly-bound nitrogen atoms having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyridine Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FI142967A 1966-05-20 1967-05-19 Förfarande för framställning av nya farmakologiskt värdefulla 2-amino- halogenbensylaminer. FI46839C (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AT273081D
DET0031195 1966-05-20

Publications (2)

Publication Number Publication Date
FI46839B FI46839B (sv) 1973-04-02
FI46839C true FI46839C (sv) 1973-07-10

Family

ID=25608208

Family Applications (1)

Application Number Title Priority Date Filing Date
FI142967A FI46839C (sv) 1966-05-20 1967-05-19 Förfarande för framställning av nya farmakologiskt värdefulla 2-amino- halogenbensylaminer.

Country Status (8)

Country Link
AT (1) AT278754B (sv)
CH (1) CH520656A (sv)
DE (1) DE1543923A1 (sv)
DK (1) DK131852C (sv)
ES (1) ES340648A2 (sv)
FI (1) FI46839C (sv)
NL (1) NL150431B (sv)
SE (1) SE356503B (sv)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2171073A1 (en) * 1995-12-04 1997-06-05 Philip C. Lang Process for the preparation of ethyl-n-(2,3 dichloro-6- nitrobenzyl) glycine

Also Published As

Publication number Publication date
DK131852B (da) 1975-09-15
SE356503B (sv) 1973-05-28
AT278754B (de) 1970-02-10
FI46839B (sv) 1973-04-02
DK131852C (da) 1976-03-15
DE1543923A1 (de) 1970-02-05
CH520656A (de) 1972-03-31
ES340648A2 (es) 1968-06-01
NL6706993A (sv) 1967-11-21
NL150431B (nl) 1976-08-16

Similar Documents

Publication Publication Date Title
FI48460C (sv) Förfarande för framställning av farmakologiskt aktiva nya amino-dihalo genfenyletylaminer.
FI48590C (sv) Förfarande för framställning av terapeutiskt användbara azaspiroalkand ionföreningar.
FI49035C (sv) Förfarande för framställning av terapeutiskt användbart 2-brom-alfa-er gokryptin.
FI47364C (sv) Förfarande för framställning av terapeutiskt värdefulla 3-indolyl-alif atiskt-syra-föreningar.
FI49716C (sv) Förfarande för framställning av 2,4-diamino-5-bensyl-pyrimidiner.
FI49290C (sv) Förfarande för framställning av nya terapeutiskt användbara bensenderi vat.
FI47365C (sv) Förfarande för framställning av nya terapeutiskt verksamma indolderiva t.
FI50334C (sv) Förfarande för framställning av 1-hydroxy-2-pyridoner.
FI49512C (sv) Förfarande för framställning av nya terapeutiskt aktiva s-triazinyl-pi perazinderivat.
FI44622C (sv) Förfarande för framställning av terapeutiskt värdefulla substituerade naftalenderivat.
FI47489C (sv) Förfarande för framställning av inflammationsförhindrande 5-(1-aroyl-3 -indolyl-metyl)-tetrazoler.
FI47577C (sv) Förfarande för framställning av 2,4,7-triamino-6-fenyl-pteridiner.
FI47092C (sv) Förfarande för framställning av terapeutiskt värdefulla blandsubstitue rade 1-fenoksy-3-alkylaminopropanoler-(2).
FI47763C (sv) Förfarande för framställning av nya neriifolinderivat.
FI46727C (sv) Förfarande för framställning av pyridazolderivat.
FI46839C (sv) Förfarande för framställning av nya farmakologiskt värdefulla 2-amino- halogenbensylaminer.
FI48724C (sv) Förfarande för framställning av N-karbamoyloxifenylkarbamater.
FI47576C (sv) Förfarande för framställning av 2-alkylamino-5-fenyl-3H-1,4-bensodiaze pin-4-oxider.
FI45045C (sv) Förfarande för framställning av nya terapeutiskt verksamma 5-nitro-2-f uryl-isoxazolderivat.
FI45856C (sv) Förfarande för framställning av nya farmakologiskt värdefulla 2-amino- halogenbensylaminer.
FI47358C (sv) Förfarande för framställning av terapeutiskt användbart 4'-demetyl-epi podofyllotoxin-beta-D-glukosid.
FI47350C (sv) Förfarande för framställning av 17alfa-propadienyl-steroider.
FI48074C (sv) Förfarande för framställning av nya kardenolid-ramnosider
FI52346C (sv) Förfarande för framställning av nya acylpenicilliner.
FI48732C (sv) Förfarande för framställning av farmakologiskt aktiva 3-substituerad-a mino-1,2,3,4-tetrahydrokarbazoler.